Top Markets
Coin of the day
Genenta Science S.p.A. Genenta Science S.p.A.

Genenta Science S.p.A.

GNTA
Rang in Aktien #28058
Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused... Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation. This innovative therapy is being developed to treat glioblastoma multiforme, specifically targeting patients whose tumors exhibit an unmethylated MGMT gene promoter. Beyond this, Genenta Science is exploring Temferon's potential application in various other solid tumor types, including locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. Established in 2014, the company maintains its headquarters in Milan, Italy.
Aktienkurs
$1.51
Zuletzt synchronisiert: 2026-07-31
Marktkapitalisierung
$28.82M
Veränderung (1 Tag)
-0.33%
Veränderung (1 Jahr)
-57.49%
Land
IT
Handel Genenta Science S.p.A. (GNTA)

Kategorie

Kursverlauf für Genenta Science S.p.A. (GNTA)
Höchster Schlusskurs: $1.55 am 2026-07-01

Niedrigster Schlusskurs: $11.33 am 2021-12-01
Kursverlauf der Aktie von Genenta Science S.p.A. von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 7.52%
2025 -68.48%
2024 -0.35%
2023 -6.83%
2022 -51.72%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$123.19 -13.26%
AU
$753.28 5.84%
CH